AGP Executive Report
Last update: 6 hours agoDrug Pricing Watch: Prague warns the EU not to let US pressure over “Most Favoured Nation” drug pricing override Czech powers over medicine pricing and reimbursement, stressing patient access and stable launches. Addiction Policy & Patient Rights: A coalition of patient groups launches a public petition against proposed CBD restrictions, urging Czech authorities to publish the evidence and decide openly ahead of the Council for Addiction Policy meeting. Public Health & Access: New analysis says up to 1.4 million Czechs live on the margins of society, with 15.4% of children at risk of poverty—an “invisible disadvantage” that costs public finances about CZK 279 billion a year. Healthcare Tech & Research: Unified Information Devices (UID) completes its acquisition of AEG ID, expanding RFID manufacturing in the Czech Republic to support traceability in healthcare and medical research. Sports & Safety: Czechia’s World Cup matchday focus includes “healthy tension” ahead of Bafana v Czechia, while separate reports highlight serious injury risks in sport and a fatal cycling crash involving a 16-year-old.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![Czechia urges caution on EU drug pricing amid US pressure [Advocacy Lab]](https://www.euractiv.com/content/uploads/sites/2/2026/06/GettyImages-1795412410.jpg)
